All lobbying filings

THE MCMANUS GROUP

THE MCMANUS GROUP filed a Q3 report for VIVEX BIOLOGICS on October 20, 2026, reporting $50,000 in lobbying income.

Lobbying for VIVEX BIOLOGICS · Biologics Company

All filings by THE MCMANUS GROUP · Everything VIVEX BIOLOGICS has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

Florida

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Education on FDA regulation of Human Cellular Tissue Products (HCTPs).

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.